Rigel Pharmaceuticals (RIGL) EBIT Margin Growth (3y) (2013 - 2026)
Rigel Pharmaceuticals (RIGL) EBIT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Rigel Pharmaceuticals |
603.18 Mn |
456.49 Mn |
54.21 Mn |
6,902.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
6,902.00 |
| Dec 31, 2025 |
2,914.00 |
| Sep 30, 2025 |
12,303.00 |
| Jun 30, 2025 |
10,357.00 |
| Mar 31, 2025 |
18,087.00 |
| Dec 31, 2024 |
13,386.00 |
| Sep 30, 2024 |
11,725.00 |
| Jun 30, 2024 |
5,089.00 |
| Mar 31, 2024 |
-7,512.00 |
| Dec 31, 2023 |
10,754.00 |
| Sep 30, 2023 |
5,907.00 |
| Jun 30, 2023 |
8,897.00 |
| Mar 31, 2023 |
-8,652.00 |
| Dec 31, 2022 |
11,663.00 |
| Sep 30, 2022 |
-2,441.00 |
| Jun 30, 2022 |
16,157.00 |
| Mar 31, 2022 |
-1,134.00 |
| Dec 31, 2021 |
-11,163.00 |
| Sep 30, 2021 |
40,909.00 |
| Jun 30, 2021 |
141,149.00 |
